SCHEMBL16886191

SCHEMBL16886191

Cc1ccc(COc2cc(F)cc(Oc3ccc(-c4nn(CC5(C)COC5)c5ncnc(N)c45)cc3)c2)n1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 2/20 0.54
▸ PIK3CA P42336 2/20 0.45
▸ PIK3CG P48736 2/20 0.45
▸ BTK Q06187 14/20 0.43
▸ NUDT14 O95848 1/20 0.41
▸ NUDT5 Q9UKK9 1/20 0.41
▸ FYN P06241 5/20 0.39
▸ LCK P06239 4/20 0.39
▸ ITK Q08881 3/20 0.39
▸ BMX P51813 3/20 0.39
▸ EGFR P00533 2/20 0.39
▸ JAK3 P52333 2/20 0.39
▸ PIK3CD O00329 1/20 0.39
▸ PIK3CB P42338 1/20 0.39
▸ PRKDC P78527 1/20 0.39
▸ SRC P12931 5/20 0.38
▸ FGR P09769 4/20 0.38
▸ YES1 P07947 3/20 0.38
▸ LYN P07948 4/20 0.38
▸ FLT3 P36888 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15613563 0.91 KCNH2 (0.53) KCNH2PIK3CAPIK3CGBTKNUDT14
SCHEMBL15613644 0.87 KCNH2 (0.55) KCNH2PIK3CAPIK3CGBTKNUDT14
SCHEMBL16886202 0.87 KCNH2 (0.55) KCNH2PIK3CAPIK3CGBTKNUDT14
SCHEMBL15613565 0.86 KCNH2 (0.54) KCNH2PIK3CAPIK3CGBTKNUDT14
SCHEMBL15613567 0.86 KCNH2 (0.56) KCNH2PIK3CAPIK3CGBTKNUDT14
SCHEMBL16886190 0.83 CYP1A2 (0.47) PIK3CAPIK3CGBTKNUDT14NUDT5
SCHEMBL15613538 0.76 SRC (0.48) PIK3CAPIK3CGBTKNUDT14NUDT5
SCHEMBL15613656 0.75 CYP1A2 (0.46) PIK3CAPIK3CGBTKNUDT14NUDT5
SCHEMBL16886171 0.74 SRC (0.50) PIK3CABTKNUDT14NUDT5FYN
SCHEMBL16886182 0.74 SRC (0.49) PIK3CAPIK3CGBTKNUDT14NUDT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9796716-B2 Selective inhibitors of Tec and Src protein kinase families PHARMASCIENCE, INC. (CA) 2017-10-24 — — US disclosed
US-20150191473-A1 PROTEIN KINASE INHIBITORS PHARMASCIENCE, INC. (CA) 2015-07-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150191473-A1 PROTEIN KINASE INHIBITORS TEC, SRC, LCK KCNH2 4209/4885PIK3CA 414/4885PIK3CG 449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback